SCHEMBL25032080

SCHEMBL25032080

CC(C)CNc1ccc([S@@](C)(=N)=O)cc1OC1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 9/20 0.40
▸ CYP19A1 P11511 2/20 0.40
▸ PDE4A P27815 5/20 0.39
▸ PDE4B Q07343 5/20 0.39
▸ PDE4C Q08493 5/20 0.39
▸ PDE4D Q08499 5/20 0.39
▸ PTGS2 P35354 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ PTGES O14684 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25032062 1.00 RORC (0.40) RORCCYP19A1PDE4APDE4BPDE4C
SCHEMBL25032061 0.86 PDE5A (0.43) RORCALDH1A1MAPTTSHRKMT2A
SCHEMBL25032058 0.79 PTGS2 (0.40) RORCPTGS2PTGS1KMT2APDE5A
SCHEMBL25033635 0.77 MEN1 (0.32) CYP19A1PDE4APDE4BPDE4CPDE4D
SCHEMBL25032067 0.77 KMT2A (0.40) RORCPDE4APDE4BPDE4CPDE4D
SCHEMBL25032060 0.75 MAPT (0.32) RORCCYP19A1PDE4APDE4BPDE4C
SCHEMBL25033211 0.75 TOP2B (0.48) PTGS2ALDH1A1MAPTTSHRKMT2A
SCHEMBL23625080 0.73 CYP19A1 (0.38) RORCCYP19A1PDE4APDE4BPDE4C
SCHEMBL25033617 0.72 PTGS2 (0.42) CYP19A1PTGS2ALDH1A1KMT2ASMN1; SMN2
SCHEMBL25032074 0.72 KMT2A (0.40) PTGS2ALDH1A1MAPTMEN1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed
Send feedback